Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced myopathies.

J S Le Quintrec, J L Le Quintrec

    Bailliere'S Clinical Rheumatology
    |April 1, 1991
    PubMed
    Summary

    Drug-induced myopathies, characterized by muscle weakness and enzyme changes, can manifest with or without pain and neuropathy. Discontinuing the causative drug is key for recovery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Proton pump inhibitors: why this gap between guidelines and prescribing practices in geriatrics?

    European journal of clinical pharmacology·2019
    Same author

    [Practical approach to usual rheumatologic and traumatic diseases in elderly patients].

    Journal de radiologie·2004
    Same author

    [Destructive arthritis of the hip in Crohn disease. 10 cases].

    Presse medicale (Paris, France : 1983)·1995
    Same author

    Case report 825. Leptomeningeal and spinal-pelvic osseous sarcoidosis.

    Skeletal radiology·1994
    Same author

    [Spinal sites, polyneuropathy and meningeal intra-spinal involvement disclosing recurrence of sarcoidosis. Diagnostic value of MRI].

    Annales de medecine interne·1994
    Same author

    [Celiac disease and dementia of rapidly fatal outcome].

    Annales de medecine interne·1993

    Area of Science:

    • Pharmacology
    • Neurology
    • Toxicology

    Background:

    • Drug-induced myopathies are a recognized complication of various medications.
    • Key symptoms include proximal muscle weakness, elevated muscle enzymes, and specific electromyographic and histological findings.

    Purpose of the Study:

    • To review and classify drug-induced myopathies.
    • To highlight diagnostic criteria and management strategies for these conditions.

    Main Methods:

    • Classification of myopathies based on clinical presentation (pain, neuropathy) and histological findings.
    • Review of literature on drugs associated with myopathy development.
    • Identification of diagnostic criteria for drug-induced myopathy.

    Main Results:

    • Drug-induced myopathies can be painless or painful, with or without associated neuropathy.
    • Specific drug classes are linked to distinct myopathy types (e.g., corticosteroids and vacuolar myopathy, zidovudine and mitochondrial myopathy).
    • Combination drug therapy can increase the risk and severity of myopathies, necessitating vigilant monitoring.

    Conclusions:

    • Establishing drug-induced myopathy requires a history of new muscle symptoms after drug initiation, a latency period, absence of other causes, and improvement upon drug withdrawal.
    • While exact mechanisms remain unclear, metabolic or immune-mediated pathways are suspected.
    • Discontinuation of the offending drug is the primary treatment, with rechallenge generally not recommended due to relapse risks.

    Related Experiment Videos